Did you know? The development of antimicrobial resistance in Neisseria gonorrhoeae (Gonorrhea) is a growing public health concern, in particular, because only one remaining class of antibiotics is recommended for its treatment.
In the late 1990s and early 2000s, ciprofloxacin resistance began to arise in Hawaii and the West Coast, and by 2004, ciprofloxacin resistance was elevated in MSM (men who have sex with men). In 2006, 13.8% of isolates exhibited resistance to ciprofloxacin, which was present in all regions of the country, including the heterosexual population. On April 13, 2007, the CDC stopped recommending fluoroquinolones as a treatment for gonococcal infections for all persons in the United States.
A major challenge to monitoring the emerging antimicrobial resistance of N. gonorrhoeae is the substantial decline in the capability of laboratories to perform essential gonorrhea culture techniques required for antibiotic testing. For more information, check out the website: cdc.gov/std/Gonorrhea
Call for your Gonorrhea test at (319)-519-0072.
